$2m/qtr for staff & corporate minimum spend. But yes, there's $1.7m we could reasonable assume as non-reocurring in Q2.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025